Advertisement

The Cost of Asthma

  • Adam Atherly
Chapter

Abstract

Asthma is one of the most costly chronic illnesses in both the developed and developing world. Asthma is a significant factor in the use of health care services, particularly emergency departments and prescription medications. In the United States, asthma is the 13th most costly medical condition and the 7th leading cause of work-loss days (Druss et al. 2002). The cost for patients with asthma in Western countries ranges from $300 to $1,300 per capita per year (Braman 2006). In the future, costs are expected to substantially increase. The purpose of this chapter is to discuss the cost of asthma to society and to evaluate the role of cost in individual access to care. The impact of cost on societies differs from that on individuals. For societies, the economic burden of an illness can help to prioritize the use of economic resources. Understanding which illnesses, from a societal perspective, use the most resources can suggest illnesses where treatments can be potentially cost saving.

Keywords

Indirect Cost Disease Management Program Asthma Medication Manage Care Plan Work Loss 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Accordini S, Bugiani M, Arossa W, Gerzeli S, Marinoni A, Olivieri M, Pirina P, Carrozzi L, Dallari R, De Togni A, de Marco R (2006) Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol 141(2):189–198CrossRefPubMedGoogle Scholar
  2. Anonymous (2002) Diverse approaches to asthma DM succeed in Medicaid populations. Dis Manag Advis 8(5):71–77Google Scholar
  3. Antonicelli L, Bucca C, Neri M, De Benedetto F, Sabbatani P, Bonifazi F, Eichler HG, Zhang Q, Yin DD (2004) Asthma severity and medical resource utilisation. Eur Respir J 23(5):723–729CrossRefPubMedGoogle Scholar
  4. Arnlind MH, Nokela M, Rehnberg C, Jonsson EW (2006) The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care. J Asthma 43(8):585–591CrossRefPubMedGoogle Scholar
  5. Ather S, Chung KD, Gregory P, Demissie K (2004) The association between hospital readmission and insurance provider among adults with asthma. J Asthma 41(7):709–713CrossRefPubMedGoogle Scholar
  6. Bender BG, Rand C (2004) Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol 4(3):191–195CrossRefPubMedGoogle Scholar
  7. Birnbaum H, Berger W, Greenberg P, Holland M, Auerbach R, Atkins K, Wanke L (2002) Direct and indirect costs of asthma to an employer. J Allergy Clin Immunol 109(2):264–270CrossRefPubMedGoogle Scholar
  8. Blais L, Beauchesne MF, Levesque S (2006) Socioeconomic status and medication prescription patterns in pediatric asthma in Canada. J Adolesc Health 38(5):607.e9–607.e16CrossRefGoogle Scholar
  9. Blanc PD, Trupin L, Eisner M, Earnest G, Katz PP, Israel L, Yelin EH (2001) The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol 54(6):610–618CrossRefPubMedGoogle Scholar
  10. Bloom B, Bruno D, Maman D, Jayadevappa R (2001) Usefulness of US cost-of-illness studies in healthcare decision making. Pharmacoeconomics 19(2):207–213CrossRefPubMedGoogle Scholar
  11. Braman SS (2006) The global burden of asthma. Chest 130(1):4S–12SCrossRefPubMedGoogle Scholar
  12. Castro M, Zimmermann NA, Crocker S, Bradley J, Leven C, Schechtman KB (2003) Asthma intervention program prevents readmissions in high healthcare users. Am J Respir Crit Care Med 168(9):1095–1099CrossRefPubMedGoogle Scholar
  13. Celik GE, Bavbek S, Paaolu G, Mungan D, Abadolu O, Harmanci E, Misirligil Z (2004) Direct medical cost of asthma in Ankara, Turkey. Respiration 71(6):587–593CrossRefPubMedGoogle Scholar
  14. Chernew M, Rosen A, Fendrick AM (2007) Value-based insurance design. Health Aff 26(2):w195–w203CrossRefGoogle Scholar
  15. Chew FT, Goh DY, Lee BW (1999) The economic cost of asthma in Singapore. Aust N Z J Med 29(2):228–233PubMedGoogle Scholar
  16. Cisternas MG, Blanc PD, Yen IH, Katz PP, Earnest G, Eisner MD, Shiboski S, Yelin EH (2003) A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 111(6):1212–1218CrossRefPubMedGoogle Scholar
  17. Colice G, Wu E, Birnbaum H, Daher M, Marynchenko M, Varghese S (2006) Healthcare and workloss costs associated with patients with persistent asthma in a privately insured population. J Occup Environ Med 48(8):794–802CrossRefPubMedGoogle Scholar
  18. Crown WH, Berndt ER, Baser O, Finkelstein SN, Witt WP, Maguire J, Haver KE (2004) Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter? Front Health Policy Res 7:95–127PubMedGoogle Scholar
  19. Dasgupta R, Guest JF (2003) Factors affecting UK primary-care costs of managing patients with asthma over 5 years. Pharmacoeconomics 21(5):357–369CrossRefPubMedGoogle Scholar
  20. David C (2004) Preventive therapy for asthmatic children under Florida Medicaid: changes during the 1990s. J Asthma 41(6):655–661CrossRefPubMedGoogle Scholar
  21. Drummond M (1992) Cost of illness studies: a major headache? Pharmacoeconomics 2(1):1–4CrossRefPubMedGoogle Scholar
  22. Druss B, Marcus SC, Olfson M, Pincus A (2002) The most expensive medical conditions in America. Health Aff 21(4):105–111CrossRefGoogle Scholar
  23. Eisenberg SS (2004) Building the case for asthma as a disease management program. Dis Manag 7(3):202–215CrossRefPubMedGoogle Scholar
  24. Ferris TG, Blumenthal D, Woodruff PG, Clark S, Camargo CA, MARC Investigators (2002) Insurance and quality of care for adults with acute asthma. J Gen Intern Med 17(12):905–913CrossRefPubMedGoogle Scholar
  25. Fox HB, McManus MA, Reichman MB (2003) Private health insurance for adolescents: is it adequate? J Adolesc Health 32(6 Suppl):12–24CrossRefPubMedGoogle Scholar
  26. Fredrickson DD, Molgaard CA, Dismuke SE, Schukman JS, Walling A (2004) Understanding frequent emergency room use by Medicaid-insured children with asthma: a combined quantitative and qualitative study. J Am Board Fam Pract 17(2):96–100CrossRefPubMedGoogle Scholar
  27. Freeman NC, Schneider D, McGarvey P (2003) The relationship of health insurance to the diagnosis and management of asthma and respiratory problems in children in a predominantly Hispanic urban community. Am J Public Health 93(8):1316–1320CrossRefPubMedGoogle Scholar
  28. Gold M, Siegel J, Russell L, Weinstein M (1996) Cost-effectiveness in health and medicine. Oxford University Press, OxfordGoogle Scholar
  29. Grupp-Phelan J, Lozano P, Fishman P (2001) Health care utilization and cost in children with asthma and selected comorbidities. J Asthma 38(4):363–373CrossRefPubMedGoogle Scholar
  30. Herjavecz I, Nagy GB, Gyurkovits K, Magyar P, Dobos K, Nagy L, Alemao E, Ben-Joseph R (2003) Cost, morbidity, and control of asthma in Hungary: The Hunair Study. J Asthma 40(6):673–681CrossRefPubMedGoogle Scholar
  31. Hodgson T (1994) Cost of illness in cost-effectiveness analysis: a review of the methodology. Pharmacoeconomics 6(6):536–552CrossRefPubMedGoogle Scholar
  32. Joshi AV, Madhavan SS, Ambegaonkar A, Smith M, Scott VG, Dedhia H (2006) Association of medication adherence with workplace productivity and health-related quality of life in patients with asthma. J Asthma 43(7):521–526CrossRefPubMedGoogle Scholar
  33. Jowers JR, Schwartz AL, Tinkelman DG, Reed KE, Corsello PR, Mazzei AA, Bender DR, Lochhead RA (2000) Disease management program improves asthma outcomes. Am J Manag Care 6(5):585–592PubMedGoogle Scholar
  34. Kiivet RA, Kaur I, Lang A, Aaviksoo A, Nirk L (2001) Costs of asthma treatment in Estonia. Eur J Public Health 11(1):89–92CrossRefPubMedGoogle Scholar
  35. Koopmanschap M (1998) Cost of illness studies. Useful for health policy? Pharmacoeconomics 14(2):143–148CrossRefPubMedGoogle Scholar
  36. Krahn MD, Berka C, Langlois P, Detsky AS (1996) Direct and indirect costs of asthma in Canada, 1990. CMAJ 154(6):821–831PubMedGoogle Scholar
  37. Lodha R, Puranik M, Kattal N, Kabra SK (2003) Social and economic impact of childhood asthma. Indian Pediatr 40(9):874–879PubMedGoogle Scholar
  38. Lozano P, Fishman P, VonKorff M, Ad Hecht J (1997) Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization. Pediatrics 99(6):757–764CrossRefPubMedGoogle Scholar
  39. Lozano P, Sullivan SD, Smith DH, Weiss KB (1999) The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol 104(5):957–963CrossRefPubMedGoogle Scholar
  40. Malone DC, Lawson KA, Smith DH (2000) Asthma: an analysis of high-cost patients. Pharm Pract Manag Q 20(1):12–20PubMedGoogle Scholar
  41. Markovitz BP, Andresen EM (2006) Lack of insurance coverage and urgent care use for asthma: a retrospective cohort study. BMC Public Health 6:14CrossRefPubMedGoogle Scholar
  42. McConnochie KM, Russo MJ, McBride JT, Szilagyi PG, Brooks AM, Roghmann KJ (1999) Socioeconomic variation in asthma hospitalization: excess utilization or greater need? Pediatrics 103(6):e75CrossRefPubMedGoogle Scholar
  43. Meng YY, Babey SH, Brown ER, Malcolm E, Chawla N, Lim YW (2006) Emergency department visits for asthma: the role of frequent symptoms and delay in care. Ann Allergy Asthma Immunol 96(2):291–297CrossRefPubMedGoogle Scholar
  44. Milton B, Whitehead M, Holland P, Hamilton V (2004) The social and economic consequences of childhood asthma across the lifecourse: a systematic review. Child Care Health Dev 30(6):711–728CrossRefPubMedGoogle Scholar
  45. Navarro RP, Parasuraman B (2005) Cost effectiveness of asthma controller therapies: influence of disease severity and other variables. Manag Care Interface 18(6):31–40PubMedGoogle Scholar
  46. Ortega AN, Belanger KD, Paltiel AD, Horwitz SM, Bracken MB, Leaderer BP (2001) Use of health services by insurance status among children with asthma. Med Care 39(10):1065–1074CrossRefPubMedGoogle Scholar
  47. Piecoro LT, Potoski M, Talbert JC, Doherty DE (2001) Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Health Serv Res 36(2):357–371PubMedGoogle Scholar
  48. Rossiter LF, Whitehurst-Cook MY, Small RE, Shasky C, Bovbjerg VE, Penberthy L, Okasha A, Green J, Ibrahim IA, Yang S, Lee K (2000) The impact of disease management on outcomes and cost of care: a study of low-income asthma patients. Inquiry 37(2):188–202PubMedGoogle Scholar
  49. Rutten van-Molken MP, Feenstra TL (2001) The burden of asthma and chronic obstructive pulmonary disease: data from The Netherlands. Pharmacoeconomics 19(Suppl 2):1–6CrossRefPubMedGoogle Scholar
  50. Rutten-van Molken MP, Postma MJ, Joore MA, Van Genugten ML, Leidl R, Jager JC (1999) Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. Respir Med 93(11):779–787CrossRefPubMedGoogle Scholar
  51. Schwenkglenks M, Lowy A, Anderhub H, Szucs TD (2003) Costs of asthma in a cohort of Swiss adults: associations with exacerbation status and severity. Value Health 6(1):75–83CrossRefPubMedGoogle Scholar
  52. Sennhauser FH, Braun-Fahrlander C, Wildhaber JH (2005) The burden of asthma in children: a European perspective. Paediatr Respir Rev 6(1):2–7CrossRefPubMedGoogle Scholar
  53. Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J (1998) Costs of asthma according to the degree of severity. Eur Respir J 12(6):1322–1326CrossRefPubMedGoogle Scholar
  54. Shiell A, Gerard K, Donaldson C (1987) Cost of illness studies: an aid to decision-making? Health Policy 8:317–323CrossRefGoogle Scholar
  55. Sin DD, Svenson LW, Cowie RL, Man SF (2003) Can universal access to health care eliminate health inequities between children of poor and nonpoor families?: a case study of childhood asthma in Alberta. Chest 124(1):51–56CrossRefPubMedGoogle Scholar
  56. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB (1997) A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 156(3):787–793PubMedGoogle Scholar
  57. Stempel DA, Spahn JD, Stanford RH, Rosenzweig JR, McLaughlin TP (2006) The economic impact of children dispensed asthma medications without an asthma diagnosis. J Pediatr 148(6):819–823CrossRefPubMedGoogle Scholar
  58. Stevens CA, Turner D, Kuehni CE, Couriel JM, Silverman M (2003) The economic impact of preschool asthma and wheeze. Eur Respir J 21(6):1000–1006CrossRefPubMedGoogle Scholar
  59. Stock S, Redaelli M, Luengen M, Wendland G, Civello D, Lauterbach KW (2005) Asthma: prevalence and cost of illness. Eur Respir J 25(1):47–53CrossRefPubMedGoogle Scholar
  60. Szucs T, Anderhub H, Rutishauser M (1999) The economic burden of asthma: direct and indirect costs in Switzerland. Eur Respir J 13:281–286CrossRefPubMedGoogle Scholar
  61. Szucs TD, Anderhub HP, Rutishauser M (2000) Determinants of health care costs and patterns of care of asthmatic patients in Switzerland. Schweiz Med Wochenschr 130(9):305–313PubMedGoogle Scholar
  62. Tinkelman D, Wilson S (2004) Asthma disease management: regression to the mean or better? Am J Manag Care 10(12):948–954PubMedGoogle Scholar
  63. Ungar WJ, Coyte PC (2000) Measuring productivity loss days in asthma patients. The Pharmacy Medication Monitoring Program and Advisory Board. Health Econ 9(1):37–46CrossRefPubMedGoogle Scholar
  64. Van Ganse E, Laforest L, Pietri G, Boissel JP, Gormand F, Ben-Joseph R, Ernst P (2002) Persistent asthma: disease control, resource utilisation and direct costs. Eur Respir J 20(2):260–267CrossRefPubMedGoogle Scholar
  65. Van Ganse E, Antonicelli L, Zhang Q, Laforest L, Yin DD, Nocea G, Sazonov Kocevar V (2006) Asthma-related resource use and cost by GINA classification of severity in three European countries. Respir Med 100(1):140–147CrossRefPubMedGoogle Scholar
  66. Wang LY, Zhong Y, Wheeler L (2005) Direct and indirect costs of asthma in school-age children. Prev Chronic Dis 2(1):A11PubMedGoogle Scholar
  67. Weiss KB, Gergen PJ, Hodgson TA (1992) An economic-evaluation of asthma in the United-States. N Engl J Med 326(13):862–866CrossRefPubMedGoogle Scholar
  68. Weiss KB, Sullivan SD, Lyttle CS (2000) Trends in the cost of illness for asthma in the United States, 1985–1994. J Allergy Clin Immunol 106(3):493–499CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Health Systems, Management, & PolicyColorado School of PublicAuroraUSA

Personalised recommendations